Cite
MLA Citation
M Staehler et al.. “Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trial.” Annals of oncology, vol. 29, 2018, pp. 2098–2104. http://access.bl.uk/ark:/81055/vdc_100095530585.0x00003d